Treatment of HER2-positive breast cancer: current status and future perspectives

@article{Arteaga2011TreatmentOH,
  title={Treatment of HER2-positive breast cancer: current status and future perspectives},
  author={Carlos L. Arteaga and Mark X. Sliwkowski and Charles Osborne and Edith A. Perez and Fabio Puglisi and Luca Gianni},
  journal={Nature Reviews Clinical Oncology},
  year={2011},
  volume={9},
  pages={16-32}
}
The advent of HER2-directed therapies has significantly improved the outlook for patients with HER2-positive early stage breast cancer. However, a significant proportion of these patients still relapse and die of breast cancer. Trials to define, refine and optimize the use of the two approved HER2-targeted agents (trastuzumab and lapatinib) in patients with HER2-positive early stage breast cancer are ongoing. In addition, promising new approaches are being developed including monoclonal… CONTINUE READING
Highly Influential
This paper has highly influenced 13 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
Related Discussions
This paper has been referenced on Twitter 5 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 286 extracted citations

Adjuvant trastuzumab for 6 months is effective in patients with HER2-positive stage II or III breast cancer.

Asian Pacific journal of cancer prevention : APJCP • 2013
View 11 Excerpts
Highly Influenced

Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2015
View 2 Excerpts
Highly Influenced

Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging

European Journal of Nuclear Medicine and Molecular Imaging • 2014
View 3 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 209 references

Recent developments in anti-cancer agents targeting PI3K, Akt and mTORC1/2.

Recent patents on anti-cancer drug discovery • 2011
View 10 Excerpts
Highly Influenced

Targets for cancer therapy in childhood sarcomas.

Cancer treatment reviews • 2010
View 6 Excerpts
Highly Influenced

Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab.

Annals of oncology : official journal of the European Society for Medical Oncology • 2012

Similar Papers

Loading similar papers…